Pediatrics

Following a multicenter study, the FDA has approved the first enzyme replacement therapy in the United States to treat alpha-mannosidosis.

The US Food and Drug Administration has approved a new treatment for pediatric patients with active psoriatic arthritis.

The US Food and Drug Administration has approved a new nonstimulant drug for the treatment for attention-deficit/hyperactivity disorder in children.

The US Food and Drug Administration has approved the marketing of the first video game-based digital therapeutic device for the treatment of children aged 8 to 12 years with attention deficit hyperactivity...

The Food and Drug Administration (FDA) has issued an enforcement policy on the manufacturing and distribution of unauthorized flavored e-cigarette products that appeal to children.

An FDA advisory committee has recommended the approval of the first therapy for peanut allergies.

The FDA has approved the first CAR T-cell therapy available in the United States for the treatment of certain pediatric patients.

The FDA has approved a new option for the treatment of central precocious puberty.

The US Food and Drug Administration has approved a new option for the treatment of a specific form of Batten disease in pediatric patients aged 3 years and older.